Earnings Report for CVS Health (CVS) in Q2 of 2023

Earnings Report for CVS Health (CVS) in Q2 of 2023

A customer exits a CVS Health Corp. store in Oakland, California, U.S., on Friday, Aug. 2, 2019. Michael Short | Bloomberg | Getty Images CVS Health reported better-than-expected second-quarter earnings and revenue on Wednesday. The company has been implementing a cost-cutting program and reducing its workforce. CVS has been focusing on expanding its health-care services …

Read more

RSV vaccines for older adults are now available at Walgreens.

RSV vaccines for older adults are now available at Walgreens.

Respiratory syncytial virus viral vaccine under research. Hailshadow | Istock | Getty Images Walgreens is now offering the respiratory syncytial virus vaccine for older adults nationwide, as announced by the pharmacy chain on Tuesday. Individuals aged 60 and above can easily schedule an appointment this week through Walgreens’ user-friendly app, convenient website, by phone, or …

Read more

CVS Health to cut 5,000 jobs in cost-cutting measures

CVS Health to cut 5,000 jobs in cost-cutting measures

A CVS Pharmacy in Washington, D.C. is shown in this image. CVS Health is planning to cut 5,000 jobs as part of its efforts to expand its healthcare offerings and reduce costs. This move comes as the company aims to prioritize investments in care delivery and technology. Despite the layoffs, CVS assures that customer-facing roles …

Read more

Pfizer (PFE) Q2 Financial Performance Report 2023

Pfizer (PFE) Q2 Financial Performance Report 2023

Pfizer, the renowned pharmaceutical company, announced its second-quarter earnings which surpassed expectations from Wall Street analysts. However, the company fell short in terms of revenue due to a significant drop in sales of Covid-related products. In comparison to the same quarter last year, Pfizer reported a decline of 54% in sales, amounting to $12.73 billion. …

Read more

Merck’s Q2 2023 Earnings Report Highlights

Merck’s Q2 2023 Earnings Report Highlights

In this illustrative photo taken in Poland on October 4, 2021, a medicine pill featuring the Merck logo is showcased on a screen in the background. NurPhoto | NurPhoto | Getty Images Merck, a leading pharmaceutical company, exceeded revenue expectations in the second quarter due to strong sales of its cancer drug Keytruda and HPV …

Read more

Possible outlook on the adoption of new vaccinations

Possible outlook on the adoption of new vaccinations

A Chicago CVS store pharmacist will be administering COVID-19 booster doses in the upcoming months. However, many Americans may not be willing to receive these booster shots due to pandemic fatigue, the belief that COVID-19 is no longer a concern, and confusion regarding personal risk levels. To combat this, public health officials and healthcare providers …

Read more

Second attempt by J&J to resolve talc cancer lawsuits ends in failure

Second attempt by J&J to resolve talc cancer lawsuits ends in failure

In this photo illustration, a container of Johnson and Johnson baby powder is displayed on April 05, 2023 in San Anselmo, California. Justin Sullivan | Getty Images A federal bankruptcy judge on Friday rejected Johnson & Johnson’s second attempt to resolve tens of thousands of lawsuits alleging the company’s talc baby powder and other talc-based …

Read more

Eli Lilly’s Obesity Medication Achieves Impressive 26% Weight Loss Results

Eli Lilly’s Obesity Medication Achieves Impressive 26% Weight Loss Results

The office of Eli Lilly in San Diego, California. Image credit: Mike Blake | Reuters An experimental drug developed by Eli Lilly has shown promising results in helping patients achieve significant weight loss. According to two studies released by the company, patients experienced an average weight reduction of 26% when using the drug alongside lifestyle …

Read more

GSK CEO predicts slower initial adoption of RSV vaccine compared to shingles shot

GSK CEO predicts slower initial adoption of RSV vaccine compared to shingles shot

GlaxoSmithKline’s CEO, Emma Walmsley, predicts that the uptake for the company’s new RSV vaccine will start slower than their successful shingles shot. However, she remains confident that the new vaccine will drive future sales. Walmsley emphasized the need to monitor uptake throughout the seasons, acknowledging that it won’t build as rapidly as the shingles vaccine …

Read more